Affymetrix and Centre for Proteomic and Genomic Research (CPGR) have entered into a service collaboration to advance genomic research services and personalized therapies in South Africa.
Under the collaboration, CPGR will use Affymetrix GeneTitan multi-channel (MC) instrument and provide gene expression and Axiom genotyping services to African researchers.
Centre for Proteomic and Genomic Research managing director Reinhard Hiller said the high throughput capability of GeneTitan combined with Axiom will meet the needs of scientists in Africa whose research projects range from small pilot to large-scale discovery to focused validation studies.
"GeneTitan MC Instrument expands our genomics service capabilities and will further enable CPGR to support cutting-edge translational research in Africa," Hiller added.
"Further, it allows discovery and validation of disease-related biomarkers economically - even when searching for very rare genetic variants.
"We expect to progress personalized medicine studies that aim to discover genetic markers specific in the African population for better diagnosis and drug treatment."
